What Are the Claims in the Ozempic and Mounjaro Lawsuit?

In lawsuits against Ozempic and Mounjaro, plaintiffs claim that these diabetes drugs caused severe health issues, including gastroparesis, ileus, and intestinal blockage. A recent lawsuit was filed by a 44-year-old woman from Louisiana who experienced severe vomiting, which resulted in the loss of her teeth.

If you are a victim of the side effects of Ozempic or Mounjaro Uptown Injury Law, PLLC is here to help you. With 15 years of experience and over $100 million secured for clients in New York, our mass tort attorneys offer free consultations and work on a contingency fee basis. Contact us at 917-540-8728 for a free case review.

What Are the Allegations in the Ozempic and Mounjaro Lawsuit?

In the lawsuits against Ozempic and Mounjaro, plaintiffs allege that these GLP-1 receptor agonists, including Ozempic, Wegovy, and Mounjaro, increase the risk of severe gastrointestinal issues. Currently, 72 lawsuits have been consolidated in the United States District Court for the Eastern District of Pennsylvania, with predictions that the MDL could eventually encompass over 20,000 cases.

The active ingredients in these drugs—semaglutide in Ozempic and Wegovy and tirzepatide in Mounjaro—are designed to slow down digestion. However, in some cases, this can nearly stop the digestive process entirely, leading to serious complications. Plaintiffs claim that the medications have caused severe side effects, including:

• Gastroparesis (delayed gastric emptying)
• Intestinal Blockages
• Severe Nausea and Vomiting
• Deep Vein Thrombosis (DVT)
• Esophageal Injury
• Ileus (Inability to Move Waste through the Intestines)
• Malnutrition-Related Issues
• Pancreatic Cancer

Other Alleged Side Effects Reported in Ozempic and Mounjaro Claims

Lawsuits involving Ozempic and Mounjaro have not only highlighted stomach-related issues but also raised concerns about other serious side effects. Plaintiffs argue that Novo Nordisk may have downplayed or hidden these risks. One emerging concern is a potential link between semaglutide, the active ingredient in Ozempic, and suicidal thoughts. The European Medicines Agency has received 150 reports of such cases among Ozempic users.

Additionally, studies reveal that drugs such as Ozempic, Rybelsus, and Wegovy are linked to an increased risk of gallbladder disease. A review of 76 studies published in the Journal of the American Medical Association supports this finding.

Recent research has also raised concerns about vision loss linked to semaglutide. A 2024 study in JAMA Ophthalmology found a possible link between semaglutide and a serious eye condition, nonarteritic anterior ischemic optic neuropathy (NAION).

When Was the Ozempic and Mounjaro Lawsuit First Filed?

The first Ozempic stomach paralysis lawsuit was filed in Louisiana on August 2, 2023. The plaintiff, Jaclyn Bjorklund, reported severe stomach pain after using Ozempic and Mounjaro. She had to go to the emergency room several times due to severe symptoms and even lost teeth because of the severity of her vomiting.

This lawsuit marked the beginning of legal actions against Ozempic and Mounjaro for serious side effects. Since then, more cases have been filed, highlighting similar issues experienced by other users.

Ozempic Lawsuit Latest News

On August 1, 2024, an Illinois man filed a new lawsuit against Novo Nordisk and Eli Lilly, alleging that they failed to warn about the risks associated with their weight loss drugs, Ozempic and Mounjaro. After switching from Ozempic to Mounjaro, the plaintiff experienced severe abdominal pain, which led to a hospital visit and surgery for an ischemic bowel. This case will join the MDL in Pennsylvania, seeking compensation for medical expenses and suffering.

Additionally, on July 9, 2024, plaintiffs gained the ability to directly file Ozempic lawsuits into MDL No. 3094, allowing for more efficient case handling and centralized pretrial proceedings in the United States District Court for the Eastern District of Pennsylvania.

Moreover, a study published on July 3, 2024, found a significant association between semaglutide, the active ingredient in Ozempic, and nonarteritic anterior ischemic optic neuropathy (NAION), a type of eye stroke causing sudden vision loss. Data showed higher incidence rates of NAION among semaglutide users compared to those on other weight-loss and diabetes medications.

Mounjaro Lawsuit Latest 2024 Updates

As of April 2024, the Mounjaro MDL has expanded to include 74 lawsuits, with more victims continuing to come forward and join the multidistrict litigation against pharmaceutical companies like Eli Lilly and Novo Nordisk.

In February 2024, the court consolidated lawsuits related to GLP-1 drugs, including Mounjaro, into an MDL in the Eastern District of Pennsylvania. This consolidation aims to streamline the legal process and gather evidence more efficiently.

Previously, in December 2023, lawyers representing victims harmed by Mounjaro and other weight loss drugs requested the consolidation of claims into an MDL to expedite the process of gathering evidence for these cases.

Profiles of Plaintiffs Who Filed Ozempic and Mounjaro Lawsuits 

These profiles highlight the personal experiences of individuals who have filed lawsuits due to severe side effects from using Ozempic and Mounjaro.

• In August 2024, an Illinois man filed a lawsuit after suffering severe abdominal pain and undergoing surgery for an ischemic bowel. He had been using Ozempic and later switched to Mounjaro for diabetes management.
• In July 2024, an Indiana woman filed a lawsuit due to severe constipation, rectal bleeding, and vomiting after using Ozempic. She had been using Ozempic to manage her diabetes and weight. Her lawsuit claims that the drug’s label did not adequately warn her or her healthcare provider about its actual risks, resulting in significant health issues.
• Jaclyn Bjorklund filed the first lawsuit in August 2023 in Louisiana. She reported experiencing severe stomach pain and a medical emergency after using Ozempic and Mounjaro. Her case brought attention to the potential dangers of these medications.

Types of Ozempic Lawsuits

The Ozempic lawsuits cover a range of severe side effects experienced by users, leading to various legal claims against the drug’s manufacturers.

Ozempic Lawsuits Stomach Paralysis

Ozempic lawsuits related to stomach paralysis primarily focus on the severe condition known as gastroparesis. This severe condition impairs the stomach’s ability to digest food, causing symptoms such as nausea, vomiting, and intense abdominal pain. Semaglutide, the active ingredient in Ozempic, is a glucagon-like peptide-1 (GLP-1) receptor agonist that slows digestion.

While Ozempic can help manage blood sugar levels in type 2 diabetes patients, it can also severely impair digestion in some cases. This has led to numerous lawsuits from individuals who have suffered from these debilitating effects, seeking compensation for their medical expenses and suffering.

Ozempic Lawsuit Gallbladder

Several lawsuits have been filed regarding Ozempic’s alleged connection to gallbladder issues. Patients have reported developing gallstones, known medically as cholelithiasis, which they believe are related to their use of Ozempic. A 2022 review of 76 studies on GLP-1 receptor agonists confirmed an association between these drugs and gallbladder diseases.

Research indicates that approximately 1 in 6 patients using Ozempic may develop gallstones. The lawsuits claim that the risks associated with gallbladder issues were not adequately communicated to patients, leading to severe health problems.

Ozempic Lawsuit Pancreatitis 

Ozempic lawsuits also include claims of pancreatitis, an inflammation or soreness of the pancreas that can cause severe abdominal pain, nausea, and vomiting. As a GLP-1 receptor agonist, Ozempic has been associated with an increased risk of this condition. 

Pancreatitis can lead to serious complications, sometimes requiring hospitalization or surgery. Lawsuits allege that the manufacturers of the diabetes drug Ozempic failed to adequately warn patients about the risk of pancreatitis and other potential side effects.

What Are the New Warnings on Ozempic Updated by the FDA?

The FDA recently updated Ozempic’s label to warn about a rare but serious side effect: intestinal blockage or ileus. This condition occurs when the intestines fail to contract properly, preventing waste from moving through the body. Symptoms of ileus include bloating, abdominal cramps, constipation, nausea, and vomiting. To date, there have been about 20 reported cases, including two that resulted in death.

Ozempic, used to manage type 2 diabetes and sometimes prescribed off-label for weight loss, is already known for causing gastrointestinal issues such as diarrhea and nausea. While the FDA has not established a direct link between semaglutide and ileus, the updated warning advises patients and healthcare providers to be aware of this potential risk.

Other GLP-1 Agonists Sued

In addition to Ozempic, several other GLP-1 receptor agonists have faced legal action over similar side effects. These include:

• Wegovy
• Rybelsus
• Trulicity
• Mounjaro
• Zepbound

What Is the Deadline to File an Ozempic and Mounjaro Lawsuit?

The deadline to file an Ozempic or Mounjaro lawsuit depends on the statute of limitations, which varies by state. In New York, you generally have 1 to 3 years from the date you discovered or should have discovered the injury to file a claim. It’s essential to consult with Ozempic lawsuit lawyers as soon as possible to ensure you meet all deadlines and gather necessary evidence. Call us at 917-540-8728 to schedule a free consultation.

Ozempic and Mounjaro Lawsuit Settlement Amounts

If you’re pursuing a lawsuit related to Ozempic or Mounjaro, settlement amounts generally range from $100,000 to $700,000. The exact amount depends on factors such as the severity of your injuries, medical treatment expenses, and the impact on your quality of life. Settlements also consider lost wages and any ongoing care you may need.

Since every case is unique, consulting with an experienced Ozempic lawyer is essential. An attorney can help you evaluate the potential value of your Ozempic claim and work to secure fair compensation for your damages. Get a free case review now!

When Will be Ozempic and Mounjaro Lawsuit be Settled?

The exact timeline for settling Ozempic and Mounjaro lawsuits is currently uncertain. As of now, federal lawsuits involving Ozempic are still in the early stages. A recent case was filed on August 1, 2024, by an Illinois man alleging severe abdominal issues after using both Ozempic and Mounjaro. This case, along with others, is part of the ongoing litigation against the drug manufacturers.

At Uptown Injury Law, PLLC, we keep you updated on the progress of these lawsuits. We provide the latest information and ensure you know your rights and options as the cases move forward.

How Can Uptown Injury Law, PLLC Ozempic Lawsuit Attorneys Help You Win Your Claim?

If you or a loved one has suffered severe side effects after using Ozempic, Uptown Injury Law, PLLC is here to help. Our experienced attorneys specialize in complex pharmaceutical litigation. We understand the challenges of these cases and will guide you through every step.

Why Choose Us?

• With years of experience and over $100 million secured, we have the expertise and resources to fight for your rights.
• We offer no-obligation consultations to evaluate your case and discuss the best legal strategies tailored to your situation.
• We work on a contingency fee basis, meaning you don’t pay any legal fees unless we successfully win your case.

Contact us at 917-540-8728 for a free consultation and take the first step toward securing the compensation you deserve.

FAQs